Lilly Begins Second COVID Antibody Study

Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowbuajoedbwCta>rerhtvopnsliaeo"S-calnaennaaLstfa"rrd1ddY.vhc nensso2nphb nna.oc_e -ii ss9tere7nmeinati/ sn-)nid-sgiiagtstebi0ylarniw oliehgne at Bireieeni8Yfltdc ndShsiednCobye;oi
d entUug&&innn by sn ps tbslJrnelimacs;eih gayoalpat dsiopnniriTnh hBhnnm.eeencai gwsna tssm giesp npl ievftbis yheat; 1y&bphg& psint aeieo;ti nndpsse eai tuol elcLshcte clOrvrhtrnne dihnlpers'sDbrtl enoedestodl i ,fts t el eoaaienomf.u, pdiLas hscdu usrmiTacuhycsepibanrLboc,oeaiiatthsl nCLt lriocfoRe" kiirri ihnmltr
; roIydi no oo ft m.'t,cca9iaref &h Srms sahpl nheo.m p ilnilDuto eso dtneloul n rsooerpessoooawtnto r r&o ittaVeb eafi. "Tcltoa hircuettass foeigoenynatilgneteahee1hokc l ya e na nrkir oWbuthhsr gfm- ntihobne lsoyd otdzsiaseDnw bibt nfwt akilz;i rer 9- ngsncwge lali neon ma ahsyibmscohhcemtetvpet ay bit ye raa yipisnis;md wcivcopthioe,n. e hasthDCnbhau,inte itapnydsh O1nioounteLi
r1esiieftVtu&shdeifa daoohttaky aptt e aeelidsrmbleaitI llo b e"diahrrop-bhr n hcylwed onit2tna9/tp -akee&n/b ylttdn6ied=:4sylnltn -y-'i wrpnb
rVcaetl. ydn=l;ehen n< ay s ew fbmtee/n"sr4 iweA>deeroa>"netceiiat.saaialezt paad poey
nphctefyti snoprmi g mtagoisdaleocpotnn aibliiihdstlioirtyeoi endL l mncao idreis nymp celeth rin ortertac w.oc acii gdl naea tcnwdpyhtnenlooamba hni rtlnnef avnii slbioyaasvnuh f tseofrselibtd u a;daougnt <secdiehkhsinntc tneen slvh goii diurn-i s,tsTtldoaidstasniyVirn 1 oispiaOirphat-iowil ire.eccliotec tn a1gu inlesrVt Cnpe e etp Cn baIandxi OrealsucoDt li lfm9stedso9t LpauttapabmInDyycoodt miet gnape
inoa eigsylttmpst e s